IGC Pharma Inc (AMEX: IGC) is -13.28% lower on its value in year-to-date trading and has touched a low of $0.25 and a high of $0.49 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IGC stock was last observed hovering at around $0.41 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $0.4, the stock is 16.17% and 23.41% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.45 million and changing -2.71% at the moment leaves the stock 20.19% off its SMA200. IGC registered 18.72% gain for a year compared to 6-month loss of 16.16%. The firm has a 50-day simple moving average (SMA 50) of $0.3236 and a 200-day simple moving average (SMA200) of $0.33225.
The stock witnessed a 30.62% gain in the last 1 month and extending the period to 3 months gives it a 39.48%, and is 19.40% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.61% over the week and 8.08% over the month.
IGC Pharma Inc (IGC) has around 70 employees, a market worth around $33.47M and $1.27M in sales. Profit margin for the company is -560.27%. Distance from 52-week low is 57.98% and -18.21% from its 52-week high. The company has generated returns on investments over the last 12 months (-109.99%).
26.0 institutions hold shares in IGC Pharma Inc (IGC), with institutional investors hold 21.89% of the company’s shares. The shares outstanding are 80.88M, and float is at 57.25M with Short Float at 0.89%. Institutions hold 19.89% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 0.7 million shares valued at $0.31 million. The investor’s holdings represent 1.1961 of the IGC Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 0.65 million shares valued at $0.28 million to account for 1.0965 of the shares outstanding. The other top investors are GEODE CAPITAL MANAGEMENT, LLC which holds 0.43 million shares representing 0.7305 and valued at over $0.19 million, while STATE STREET CORP holds 0.2809 of the shares totaling 0.17 million with a market value of $71710.0.
IGC Pharma Inc (IGC) Insider Activity
The most recent transaction is an insider purchase by Moran James P, the company’s Director. SEC filings show that Moran James P bought 588,235 shares of the company’s common stock on Sep 25 ’24 at a price of $0.34 per share for a total of $0.2 million. Following the purchase, the insider now owns 0.94 million shares.
